Drug intelligence / Profile preview

Allergovit

Development stage
Phase 4
Lead developer
Allergopharma
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Peptides, Peptide-based Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Allergovit is a brand of allergen immunotherapy (also known as desensitisation or specific immunotherapy) used primarily for the treatment of severe hayfever and allergic rhinitis caused by grass or tree pollens. It consists of natural pollen extracts (allergoids), which are modified allergens designed to reduce allergenicity while retaining their ability to induce immune tolerance. The therapy works by gradually exposing patients to increasing doses of the relevant pollen allergens via subcutaneous injection, aiming to "reset" or modulate the immune response and reduce allergic symptoms over time. The mechanism involves immunomodulation—shifting the immune system away from an IgE-mediated allergic response towards tolerance. Clinical studies show significant long-term symptom reduction in most patients after a course lasting approximately 30 months[1][2][4][5].

Brand names
Allergovit
Other names
Allergovit 6 GrassesAllergovit6 GrassesAllergovit-6 GrassesAllergovit BirchGrass pollen allergoidsBirch pollen allergoid

Beyond the preview

Go deeper on Allergovit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allergovit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call